GGPOKER
26.4.2021 17:27:12 CEST | Business Wire | Press release
The World Series of Poker (WSOP) and GGPoker today announce a comprehensive schedule of online WSOP events kicking off with the WSOP Super Circuit Online Series on Saturday, May 1 and WSOP Online 2021 International tournament starting Sunday, Aug 1. Events open to international players will be hosted on the GGPoker app, while US players will enter via the WSOP.com online poker platform.
2021 WSOP Events at GGPoker and WSOP.com:
- WSOP Super Circuit Online Series at GGPoker - May 1-May 30
- WSOP Online 2021 (Domestic US) at WSOP.com - July 1-Aug. 1
- WSOP Online 2021 at GGPoker (International) - Aug. 1-Sept. 12
- WSOP Las Vegas “Main Event” satellites - Aug. 1-Oct. 1
- WSOP Winter Online Super Circuit at GGPoker - Dates TBC
WSOP action kicks off at GGPoker with the $100 million-guaranteed WSOP Super Circuit Online Series, scheduled from May 1 through May 30. A total of 18 WSOP Circuit ring events will headline the series, with a coveted WSOP Circuit gold ring awarded to each tournament’s winner. Furthermore, for the first time, an additional two WSOP Circuit rings will be awarded to cash game specialists; No-Limit Hold’em and Pot-Limit Omaha/Pot Limit Omaha-5 leaderboards will determine the invitation list for these two final-table-only events.
Dozens of WSOP gold bracelets will be up for grabs in the previously-announced WSOP 2021 Online series, which runs on WSOP.com for US players from July 1 through Aug. 1 and at GGPoker for international players from Aug. 1 through Sept. 12. A total of 33 bracelets will be won on WSOP.com, with the same number of bracelet tournaments at GGPoker. Last year’s WSOP Online Main Event at GGPoker was awarded the Guinness World Record for the largest prize pool in a single online poker tournament, boasting a massive $27.5 million in prizes.
Online satellite tournaments awarding tickets to the live World Series of Poker $10,000 No-Limit Hold’em World Championship, better known as “The Main Event®”, will also be hosted on WSOP.com and at GGPoker beginning Aug. 1. “The Main Event” is expected to begin on Nov. 4 in Las Vegas at the Rio All-Suite Hotel & Casino, and is the most famous live poker event on the planet. It has been held annually since 1970 and draws thousands of players from more than 100 countries, creating poker history with each new champion.
GGPoker will also host the WSOP Winter Online Super Circuit later in the year, with dates to be confirmed.
“The bar has been set with last year’s record-breaking series, but we’re hoping to raise it even higher this year,” said Gregory Chochon, Director of the World Series of Poker. “One of our goals is to provide as many people the chance to become champions as possible. However, we know not everyone can or is comfortable traveling yet, so continuing a robust online bracelet offering in 2021 is a must.”
Added GGPoker Head of Poker Operations Steve Preiss, “When GGPoker & WSOP partnered in 2020, we broke world records. Our plans for 2021 are to offer even more to our customers. With massive tournaments, WSOP gold bracelets & rings, and a route into the live WSOP Main Event in November, we hope players will love what we have in store for them.”
Full details on all online WSOP events will be released over the coming weeks and months, and will include tournament dates, buy-ins and other important information.
New GGPoker players are eligible to claim the poker room’s Welcome Bonus, earn additional rewards with the Honeymoon for Newcomers promotion and automatically join GGPoker’s Fish Buffet loyalty program, with regular cash prizes on offer.
For more information on the WSOP Super Circuit Online Series, please visit: https://en.ggpoker.com/tournaments/wsop-super-circuit-online-series/
About GGPoker : GGPoker is one of the world’s leading online poker rooms, with a global player base. It offers a range of innovative games and features such as the patented Rush & Cash poker, All-In or Fold, Flip & Go, Spin & Gold, integrated staking platform, SnapCam video messaging, the ability to squeeze your hole cards, PokerCraft, and Smart HUD, all designed to enhance gaming experiences and make poker more fun than ever. In 2020, GGPoker hosted WSOP tournaments, including the world record-breaking WSOP Online main event and the WSOP 2020 Main Event, while in April 2021, GGPoker hosts the $150M-guaranteed GG Spring Festival.
Find out more about GGPoker at GGPoker.com and on Facebook and Twitter .
About the World Series of Poker : The World Series of Poker® is the largest, richest and most prestigious gaming event in the world, having awarded more than $3.29 billion in prize money and the prestigious gold bracelet, globally recognized as the sport’s top prize. Featuring a comprehensive slate of tournaments in every major poker variation, the WSOP is poker’s longest-running tournament in the world, dating back to 1970. In 2019, the event attracted 187,298 entrants from 118 different countries to the Rio All-Suite Hotel & Casino in Las Vegas and awarded more than $293 million in prize money. In addition, the WSOP has formed groundbreaking alliances in broadcasting, digital media and corporate sponsorships, while successfully expanding the brand internationally with the advent of WSOP Europe in 2007 and the WSOP Asia-Pacific in 2013 and the WSOP International Circuit Series in 2015. For more information on the WSOP, please visit www.wsop.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210426005638/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom